Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 2 Neoplasms 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sarcoma 1 Penile Neoplasms 1 PD-L1 Positive Mutation Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 Hemangiosarcoma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Fluorouracil 34 Leucovorin 31 Oxaliplatin 25 Irinotecan 19 Capecitabine 13 Folfox protocol 12 Cetuximab 12 Chemotherapy, Adjuvant 11 Bevacizumab 9 Neoadjuvant Therapy 8 Drug Therapy 8 XELOX 7 Laparoscopy 7 Endoscopic Mucosal Resection 5 Colonoscopy 5 Surgical Procedures, Operative 4 Gemcitabine 4 Tegafur 3 Radiotherapy 3 Propofol 3 Preoperative Exercise 3 Panitumumab 3 Fentanyl 3 Curcumin 3 Colectomy 3 Aspirin 3 raltitrexed 2 Surveys and Questionnaires 2 Sodium Chloride 2 Simvastatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colonic Neoplasms × avelumab × Clear all

NCT03608046 2020-10-22

AVETUXIRI

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡